{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T03:16:42Z","timestamp":1787887002049,"version":"build-2784847793"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/s41398-026-04144-w","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:23:25Z","timestamp":1781843005000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Discovery of a potential novel pharmacogenomic biomarker on ANK3 gene for liafensine, a triple reuptake inhibitor for treatment-resistant depression"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1642-3710","authenticated-orcid":false,"given":"Wen","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3949-1188","authenticated-orcid":false,"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Whitaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zafrin","family":"Dhali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinkun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"4144_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/wps.21120","volume":"22","author":"RS McIntyre","year":"2023","unstructured":"McIntyre RS, Alsuwaidan M, Baune BT, Berk M, Demyttenaere K, Goldberg JF, et al. Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions. World Psychiatry. 2023;22:394\u2013412.","journal-title":"World Psychiatry"},{"key":"4144_CR2","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","volume":"163","author":"AJ Rush","year":"2006","unstructured":"Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163:1905\u201317.","journal-title":"Am J Psychiatry"},{"key":"4144_CR3","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1176\/appi.ajp.2020.20081251","volume":"178","author":"RS McIntyre","year":"2021","unstructured":"McIntyre RS, Rosenblat JD, Nemeroff CB, Sanacora G, Murrough JW, Berk M, et al. Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation. Am J Psychiatry. 2021;178:383\u201399.","journal-title":"Am J Psychiatry"},{"key":"4144_CR4","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1176\/appi.ajp.2019.19040423","volume":"176","author":"AF Schatzberg","year":"2019","unstructured":"Schatzberg AF. A word to the wise about intranasal esketamine. Am J Psychiatry. 2019;176:422\u20134.","journal-title":"Am J Psychiatry"},{"key":"4144_CR5","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1097\/JCP.0000000000000335","volume":"35","author":"Z Bhagwagar","year":"2015","unstructured":"Bhagwagar Z, Torbeyns A, Hennicken D, Zheng M, Dunlop BW, Mathew SJ, et al. Assessment of the efficacy and safety of BMS-820836 in patients with treatment-resistant major depression: results from 2 randomized, double-blind studies. J Clin Psychopharmacol. 2015;35:454\u20139.","journal-title":"J Clin Psychopharmacol"},{"key":"4144_CR6","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559\u201375.","journal-title":"Am J Hum Genet"},{"key":"4144_CR7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1006\/geno.1995.1023","volume":"27","author":"D Kapfhamer","year":"1995","unstructured":"Kapfhamer D, Miller DE, Lambert S, Bennett V, Glover TW, Burmeister M. Chromosomal Localization of the AnkyrinG Gene (ANK3\/Ank3) to Human 10q21 and Mouse 10. Genomics. 1995;27:189\u201391.","journal-title":"Genomics"},{"key":"4144_CR8","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/s12276-022-00798-w","volume":"54","author":"S Yoon","year":"2022","unstructured":"Yoon S, Piguel NH, Penzes P. Roles and mechanisms of ankyrin-G in neuropsychiatric disorders. Exp Mol Med. 2022;54:867\u201377.","journal-title":"Exp Mol Med"},{"key":"4144_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/YIC.0b013e32832a8eb2","volume":"24","author":"SA Montgomery","year":"2009","unstructured":"Montgomery SA, M\u00f6ller HJ. Is the significant superiority of escitalopram compared with other antidepressants clinically relevant?. Int Clin Psychopharmacol. 2009;24:111\u20138.","journal-title":"Int Clin Psychopharmacol"},{"key":"4144_CR10","doi-asserted-by":"crossref","unstructured":"Wang G, Aguado M, Spear MA, Alphs L, Chen C, Huang H, et al. ANK3 as a novel genetic biomarker for liafensine in treatment-resistant depression: The ENLIGHTEN randomized clinical trial. JAMA Psychiatry. 2025;Epub ahead of print.","DOI":"10.1001\/jamapsychiatry.2025.2416"},{"key":"4144_CR11","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1126\/science.1099314","volume":"304","author":"JG Paez","year":"2004","unstructured":"Paez JG, J\u00e4nne PA, Lee JC, Tracy S, Greulich H, Gabriel S, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science. 2004;304:1497\u2013500.","journal-title":"Science"},{"key":"4144_CR12","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1056\/NEJMoa040938","volume":"350","author":"TJ Lynch","year":"2004","unstructured":"Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non\u2013small-cell lung cancer to gefitinib. N Engl J Med. 2004;350:2129\u201339.","journal-title":"N Engl J Med"},{"key":"4144_CR13","doi-asserted-by":"publisher","first-page":"3992","DOI":"10.1158\/0008-5472.CAN-06-0191","volume":"66","author":"A Li\u00e8vre","year":"2006","unstructured":"Li\u00e8vre A, Bachet JB, Le Corre D, Boige V, Landi B, Emile JF, et al. KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer. Cancer Res. 2006;66:3992\u20135.","journal-title":"Cancer Res"},{"key":"4144_CR14","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.4155\/fmc.15.134","volume":"7","author":"H Sharma","year":"2015","unstructured":"Sharma H, Santra S, Dutta A. Triple reuptake inhibitors as potential next-generation antidepressants: a new hope?. Future Med Chem. 2015;7:2385\u2013406.","journal-title":"Future Med Chem"},{"key":"4144_CR15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"A Auton","year":"2015","unstructured":"Auton A, Abecasis GR, Altshuler DM, Durbin RM, Abecasis GR, Bentley DR, et al. A global reference for human genetic variation. Nature. 2015;526:68\u201374.","journal-title":"Nature"},{"key":"4144_CR16","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1126\/science.1169789","volume":"323","author":"K Kizhatil","year":"2009","unstructured":"Kizhatil K, Baker SA, Arshavsky VY, Bennett V. Ankyrin-G promotes cyclic nucleotide-gated channel transport to rod photoreceptor sensory cilia. Science. 2009;323:1614\u20137.","journal-title":"Science"},{"key":"4144_CR17","doi-asserted-by":"publisher","first-page":"8221","DOI":"10.1074\/jbc.M413351200","volume":"280","author":"C Lopez","year":"2005","unstructured":"Lopez C, M\u00e9tral S, Eladari D, Drevensek S, Gane P, Chambrey R, et al. The ammonium transporter RhBG: requirement of a tyrosine-based signal and ankyrin-G for basolateral targeting and membrane anchorage in polarized kidney epithelial cells. J Biol Chem. 2005;280:8221\u20138.","journal-title":"J Biol Chem"},{"key":"4144_CR18","doi-asserted-by":"publisher","first-page":"26557","DOI":"10.1074\/jbc.M803120200","volume":"283","author":"F Sohet","year":"2008","unstructured":"Sohet F, Colin Y, Genetet S, Ripoche P, M\u00e9tral S, Le Van Kim C, et al. Phosphorylation and ankyrin-G binding of the C-terminal domain regulate targeting and function of the ammonium transporter RhBG. J Biol Chem. 2008;283:26557\u201367.","journal-title":"J Biol Chem"},{"key":"4144_CR19","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1126\/science.1085167","volume":"300","author":"JJ Garrido","year":"2003","unstructured":"Garrido JJ, Giraud P, Carlier E, Fernandes F, Moussif A, Fache MP, et al. A targeting motif involved in sodium channel clustering at the axonal initial segment. Science. 2003;300:2091\u20134.","journal-title":"Science"},{"key":"4144_CR20","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1016\/S0140-6736(13)60855-7","volume":"381","author":"N Craddock","year":"2013","unstructured":"Craddock N, Sklar P. Genetics of bipolar disorder. Lancet. 2013;381:1654\u201362.","journal-title":"Lancet"},{"key":"4144_CR21","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/mp.2016.65","volume":"21","author":"S Rangaraju","year":"2016","unstructured":"Rangaraju S, Levey DF, Nho K, Jain N, Andrews KD, Le-Niculescu H, et al. Mood, stress and longevity: convergence on ANK3. Mol Psychiatry. 2016;21:1037\u201349.","journal-title":"Mol Psychiatry"},{"key":"4144_CR22","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nature13595","volume":"511","author":"Schizophrenia Working Group of the Psychiatric Genomics C.","year":"2014","unstructured":"Schizophrenia Working Group of the Psychiatric Genomics C. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511:421\u20137.","journal-title":"Nature"},{"key":"4144_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4339","volume":"5","author":"TW Muhleisen","year":"2014","unstructured":"Muhleisen TW, Leber M, Schulze TG, Strohmaier J, Degenhardt F, Treutlein J, et al. Genome-wide association study reveals two new risk loci for bipolar disorder. Nat Commun. 2014;5:3339.","journal-title":"Nat Commun"},{"key":"4144_CR24","doi-asserted-by":"publisher","first-page":"10479","DOI":"10.1073\/pnas.1700689114","volume":"114","author":"S Zhu","year":"2017","unstructured":"Zhu S, Cordner ZA, Xiong J, Chiu CT, Artola A, Zuo Y, et al. Genetic disruption of ankyrin-G in adult mouse forebrain causes cortical synapse alteration and behavior reminiscent of bipolar disorder. Proc Natl Acad Sci USA. 2017;114:10479\u201384.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4144_CR25","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.ajhg.2018.04.002","volume":"102","author":"MD Gallagher","year":"2018","unstructured":"Gallagher MD, Chen-Plotkin AS. The Post-GWAS Era: from association to function. Am J Hum Genet. 2018;102:717\u201330.","journal-title":"Am J Hum Genet"},{"key":"4144_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47092-z","volume":"15","author":"A Gonz\u00e1lez-Iglesias","year":"2024","unstructured":"Gonz\u00e1lez-Iglesias A, Arcas A, Domingo-Muelas A, Mancini E, Galcer\u00e1n J, Valc\u00e1rcel J, et al. Intron detention tightly regulates the stemness\/differentiation switch in the adult neurogenic niche. Nat Commun. 2024;15:2837.","journal-title":"Nat Commun"},{"key":"4144_CR27","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.biocel.2017.06.016","volume":"91","author":"O Shaul","year":"2017","unstructured":"Shaul O. How introns enhance gene expression. Int J Biochem Cell Biol. 2017;91:145\u201355.","journal-title":"Int J Biochem Cell Biol"},{"key":"4144_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104953","volume":"100","author":"D Ruiz-Gabarre","year":"2024","unstructured":"Ruiz-Gabarre D, Vall\u00e9s-Saiz L, Carnero-Espejo A, Ferrer I, Hern\u00e1ndez F, Garcia-Escudero R, et al. Intron retention as a productive mechanism in human MAPT: RNA species generated by retention of intron 3. EBioMedicine. 2024;100:104953.","journal-title":"EBioMedicine"},{"key":"4144_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-024-10558-x","volume":"25","author":"P Dvorak","year":"2024","unstructured":"Dvorak P, Hlavac V, Hanicinec V, Rao BH, Soucek P. Genes divided according to the relative position of the longest intron show increased representation in different KEGG pathways. BMC Genomics. 2024;25:649.","journal-title":"BMC Genomics"},{"key":"4144_CR30","doi-asserted-by":"publisher","first-page":"D1122","DOI":"10.1093\/nar\/gkac1020","volume":"51","author":"D Huang","year":"2022","unstructured":"Huang D, Feng X, Yang H, Wang J, Zhang W, Fan X, et al. QTLbase2: an enhanced catalog of human quantitative trait loci on extensive molecular phenotypes. Nucleic Acids Res. 2022;51:D1122\u2013D8.","journal-title":"Nucleic Acids Res"},{"key":"4144_CR31","doi-asserted-by":"publisher","first-page":"D1467","DOI":"10.1093\/nar\/gkae1128","volume":"53","author":"A Buniello","year":"2024","unstructured":"Buniello A, Suveges D, Cruz-Castillo C, Llinares MB, Cornu H, Lopez I, et al. Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Res. 2024;53:D1467\u2013D75.","journal-title":"Nucleic Acids Res"},{"key":"4144_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-024-02998-6","volume":"14","author":"NT Sharew","year":"2024","unstructured":"Sharew NT, Clark SR, Schubert KO, Amare AT. Pharmacogenomic scores in psychiatry: systematic review of current evidence. Transl Psychiatry. 2024;14:322.","journal-title":"Transl Psychiatry"},{"key":"4144_CR33","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/hup.2424","volume":"29","author":"SA Montgomery","year":"2014","unstructured":"Montgomery SA, Nielsen RZ, Poulsen LH, H\u00e4ggstr\u00f6m L. A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin-noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine. Hum Psychopharmacol. 2014;29:470\u201382.","journal-title":"Hum Psychopharmacol"},{"key":"4144_CR34","unstructured":"CDER. (CENTER FOR DRUG EVALUATION AND RESEARCH): Spravato (Esketamine) NDA 211243 Clinical Review 2019 https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2019\/211243Orig1s000MedR.pdf."}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04144-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04144-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04144-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T02:17:56Z","timestamp":1787883476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04144-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4144"],"URL":"https:\/\/doi.org\/10.1038\/s41398-026-04144-w","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"30 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"WL, JW, ZD, XL, HS, HL, JZ, and TS had\/have equity in Denovo Biopharma and are\/were employed at Denovo Biopharma. GW reports consulting fees from Boehringer Ingelheim, Janssen, Otsuka Pharmaceutical Co., Ltd.; and is Chairman of China Association for Mental Health.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Both CN162006 (NCT01309945) and CN162007 (NCT01369095) were conducted in accordance with the aims and principles of the International Council for Harmonisation (ICH), Good Clinical Practice (GCP), and the Declaration of Helsinki. All patients provided written informed consent before study participation. The real world data from Beijing Anding Hospital Depression Cohort was approved by Ethic Committee with EC registration number of [2019]-006 by Beijing Municipal Health Commission Ethics Committee.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"433"}}